Ezogabine - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for ezogabine and what is the scope of patent protection?
Ezogabine
is the generic ingredient in one branded drug marketed by Glaxosmithkline and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for ezogabine
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 102 |
Clinical Trials: | 16 |
Patent Applications: | 2,259 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ezogabine at DailyMed |
Recent Clinical Trials for ezogabine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Xenon Pharmaceuticals Inc. | Phase 3 |
James Murrough | Phase 2 |
National Institute of Mental Health (NIMH) | Phase 2 |
US Patents and Regulatory Information for ezogabine
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | POTIGA | ezogabine | TABLET;ORAL | 022345-001 | Jun 10, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | POTIGA | ezogabine | TABLET;ORAL | 022345-004 | Jun 10, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | POTIGA | ezogabine | TABLET;ORAL | 022345-002 | Jun 10, 2011 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |